Amphetamine Use Revealing Hypertrophic Cardiomyopathy in a Young Patient
- PMID: 35464329
- PMCID: PMC8993442
- DOI: 10.14740/jmc3915
Amphetamine Use Revealing Hypertrophic Cardiomyopathy in a Young Patient
Abstract
Adrenergic overstimulation in long term can lead to a hyperdynamic myocardium and give rise to hypertrophy and ultimately to heart failure. Amphetamine use is a common cause of neurohormonal activation, which gives rise to such adverse cardiovascular events. However, hypertrophy of myocardium in young patients, even due to apparently obvious causes, should always be considered as a red flag and a further diagnostic downstream should take place, in order to exclude genetic causes. We present a case of a young man with chronic use of amphetamine and an incidental finding of hypertrophic cardiomyopathy.
Keywords: Cardiac MRI; Hypertrophic cardiomyopathy; Myopericarditis; Sudden cardiac death.
Copyright 2022, Misimi et al.
Conflict of interest statement
Authors have no conflict of interest to declare.
Figures
References
-
- European drug report 2020. Monitoring Centre for Drugs and Drug Addiction. 2020. https://www.emcdda.europa.eu/edr2020_en.
Publication types
LinkOut - more resources
Full Text Sources